HSUK:PA:PA-HSBC UK SUS EQ ETF (EUR)

ETF | Others |

Last Closing

USD 23.31

Change

-0.15 (-0.64)%

Market Cap

N/A

Volume

14.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.18 (+0.38%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.40 (+0.25%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.18 (+0.29%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.06 (+0.16%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.10 (-0.42%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-2.60 (-0.52%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.00 (+0.28%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.14 (+0.24%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.03 (-0.43%)

USD 5.25B

ETFs Containing HSUK:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.07% 73% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.07% 73% C 68% D+
Trailing 12 Months  
Capital Gain 19.34% 76% C+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.34% 73% C 76% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.42% 42% F 53% F
Dividend Return 6.42% 69% C- 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.75% 88% B+ 92% A
Risk Adjusted Return 82.80% 80% B- 88% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike